Delivery Order SPE2DB22D1106-SPE2DB24FEEW8
Award Date 3/14/24
Potential Completion Date 3/15/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,093.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 10 mg pharmaceutical kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 20 mg kits. The order has a ceiling value of $15,006.05 and a completion date of April 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract, valued at $2,648.30, to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 20 mg kits. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,296.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Sandostatin LAR Depot 20 mg kits. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The Defense Logistics Agency (DLA) awarded a $6,562.82 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 30 mg kits. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebegen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Sandostatin LAR Depot 10 mg kits, with a completion date of March 8, 2024 and a potential value of $12,290.48. The contract was not set aside for any special business designation. In addition to this specific delivery order,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568189974 Sandostatin LAR Depot 10 mg kits. The contract has a firm fixed price of $2,030.13 and a completion date of May 9, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,841.09, is for the provision of Sandostatin LAR Depot 30 mg kits. The award has an ultimate completion date of May 30, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEEW8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,017.02 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Sandostatin LAR Depot 30 mg kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00, for the supply of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order has an ultimate completion date of March 15, 2024. There is no set-aside designation for this award.
Generated 6/13/24, 10:31 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 3/14/24 |